Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Neuropathic Pain After Breast Surgery

NCT03124511 is registered in ClinicalTrials.gov with Danish Pain Research Center as lead sponsor.

NCT NCT03124511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03124511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Neuropathic Pain After Breast Surgery
Lead sponsor
Danish Pain Research Center
Phase
Observational
Overall status
Completed
Start date
August 15, 2017
Completion date
August 1, 2021
Enrollment
150 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic chemotherapy-induced neuropathic pain, chronic chemotherapy-induced pain, chronic chemotherapy-induced peripheral neuropathy, chronic neuropathic pain, postoperative, chronic pain, postoperative